NRX Pharmaceuticals EPS Diluted from Discontinued Operations (Quarterly) Analysis

NRX Pharmaceuticals, Inc. (NRXP)

2.185 -0.08 (-3.74%) USD | NASDAQ | Jan 20, 16:00

2.185 0.00 (0.00%) After-Hours: 16:07

View EPS Diluted from Discontinued Operations (Quarterly) for NRXP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Discontinued Operations (Quarterly) Benchmarks

Start Trial

Synergy CHC Corp.	--
Acurx Pharmaceuticals, Inc.	--
IGC Pharma, Inc.	--
NeOnc Technologies Holdings, Inc.	--
CEL-SCI Corp.	--